Related Experiment Videos
Cutaneous mycobacterial infection post intravesical BCG installation
Y H Ng1, S P Bramwell, T J Palmer
1Department of Urology, Raigmore Hospital, Inverness, UK.
Summary
Disseminated tuberculous lesions after intravesical Bacillus Calmette-Guérin (BCG) therapy are rare. This report details the first case of a tuberculous skin lesion in a patient undergoing this treatment.
Area of Science:
- Oncology
- Immunology
- Infectious Diseases
Background:
- Intravesical Bacillus Calmette-Guérin (BCG) is a standard immunotherapy for non-muscle-invasive bladder cancer.
- Disseminated BCG infection is a rare but serious complication.
- Cutaneous manifestations of disseminated BCG are exceptionally uncommon.
Observation:
- A patient undergoing intravesical BCG therapy developed a skin lesion.
- The lesion was diagnosed as tuberculous in origin.
- This represents the first reported instance of a cutaneous tuberculous lesion in this clinical context.
Findings:
- The patient presented with a disseminated tuberculous cutaneous lesion.
- This finding highlights a rare adverse event associated with intravesical BCG therapy.
- Prompt identification and treatment are crucial for managing such cases.
Implications:
- This case expands the spectrum of known BCG complications.
- Clinicians should maintain a high index of suspicion for tuberculous lesions in patients receiving intravesical BCG.
- Early diagnosis and appropriate anti-tuberculous treatment are essential for favorable outcomes.